|
|
|
|
|
Management Team
- William D. Young, Chairman of the Board and Chief Executive Officer
- Michael P. Bates, MD, Vice President, Clinical Research
- Timothy G. Henn, Vice President, Finance
- Kathy L. Hibbs, Senior Vice President, General Counsel
- Kenneth N. Hitchner, Vice President, Pharmaceutical Collaborations
- Alfred G. Merriweather, Senior Vice President, Chief Financial Officer
- Gordon Parry, PhD, Vice President of Research and Development, Oncology
- Christos J. Petropoulos, PhD, Vice President, Research and Development, Virology and Chief Scientific Officer
- Michael G. Vicari, Vice President, Sales
- William J. Welch, Senior Vice President and Chief Commercial Officer
- Jeannette M. Whitcomb, PhD, Vice President, Operations
- Patricia Wray, Vice President, Human Resources
William D. Young is Chairman of the Board and Chief Executive Officer. He has served as our Chief Executive Officer since November 1999 and has served as the Chairman of the Board since May 1999. From March 1997 to October 1999, Mr. Young was Chief Operating Officer at Genentech, Inc., a biotechnology company. As COO at Genentech, Mr. Young was responsible for all of the company's development, operations and commercial functions. Mr. Young joined Genentech in 1980 as Director of Manufacturing and Process Sciences and held various executive positions prior to becoming COO. Prior to joining Genentech, Mr. Young was employed by Eli Lilly and Company for 14 years. Mr. Young is a member of the board of directors of Biogen IDEC and Theravance, Inc. He received his bachelor's degree in chemical engineering from Purdue University, his MBA from Indiana University and an honorary doctorate in engineering from Purdue University. Mr. Young was elected to the National Academy of Engineering in 1993 for his contributions to biotechnology.
|
 |
|
Michael P. Bates, MD is Vice President of Clinical Research. He joined our Clinical Research group as Medical Director in January 2001, was promoted to Senior Director in 2003 and was named Vice President of Clinical Research in June 2004. Prior to joining Monogram, Dr. Bates completed his internship and residency in Internal Medicine at the University of California, San Francisco, before pursuing fellowship training in Cardiology at Duke University in Durham, North Carolina, and in Infectious Diseases at the University of Washington in Seattle, Washington. Following two years on the junior faculty at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, Dr. Bates moved to industry. Dr. Bates was Regional Medical Director/Medical Liaison for Roche, focusing on virology from February 1999 to December 2000.
|
 |
|
Timothy G. Henn joined Monogram in April 2007 as our Vice President, Finance. Mr. Henn brings more than 20 years of finance experience, including roles at several public companies, and has been instrumental in numerous strategic, financial and operational activities. Most recently he served as Vice President, Finance and Administration for Dynavax Technologies Corporation. Prior to Dynavax, Mr. Henn served as Senior Vice President, Finance and Corporate Controller at Incyte Corporation. Mr. Henn received his M.B.A. from Golden Gate University and his B.S. in accounting from the University of Illinois.
|
 |
|
Kathy L. Hibbs is Senior Vice President, General Counsel, and joined in April 2001. Prior to joining Monogram, Ms. Hibbs was Vice President and General Counsel for Multitude, Inc., an Internet telecommunications company. Prior to that, from 1996 to 2000, she served as Senior Corporate Counsel at Varian Medical Systems, Inc., a leading manufacturer of integrated cancer therapy systems. At Varian, she was responsible for numerous legal matters including regulatory compliance, employment law, litigation and SEC reporting. Before her employment with Varian, Ms. Hibbs worked as a litigator for two California law firms and dealt with various legal issues, including civil rights and securities law. She received her JD degree from the University of California, Hastings College of Law, and her bachelor's degree in political science from the University of California, Riverside.
|
 |
|
Kenneth N. Hitchner is Vice President of Pharmaceutical Collaborations. He joined Monogram as Director of Project Management in May 1999 and was named Vice President of Pharmaceutical Collaborations in October 2003. From December 1997 to May 1999, Mr. Hitchner was the Director of Project Management at Gilead Sciences. Prior to Gilead, he was with Genentech for 15 years and held a number of positions including Director of Product Development and Global Project Leader. Mr. Hitchner received his bachelor's degree in zoology from DePauw University and a master's degree in biology from San Francisco State University.
|
 |
|
Alfred G. Merriweather is Senior Vice President, Chief Financial Officer. From December 2001 to December 2004, Mr. Merriweather served as Vice President, Finance, Chief Financial Officer and Secretary of ACLARA. From 1999 to 2001, he was Vice President and Chief Financial Officer for Citadon, Inc., a software company. From 1996 to 1999, Mr. Merriweather was Vice President of Finance and Chief Financial Officer of Symphonix Devices, Inc., a manufacturer of implantable medical devices. From 1993 to 1996, Mr. Merriweather was Vice President of Finance and Chief Financial Officer of LipoMatrix, Inc., a medical device company based in Neuchatel, Switzerland. Prior to that, Mr. Merriweather was Vice President of Finance and Chief Financial Officer of Laserscope, a manufacturer of surgical laser systems. Mr. Merriweather holds a BA from the University of Cambridge, England.
|
 |
|
Gordon Parry, PhD, is Vice President of Research and Development, Oncology. Dr. Parry is responsible for the further development of Monogram’s proprietary VeraTag™ technology platform and the first product based on that platform – the HERMark™ Breast Cancer Assay. Dr. Parry joined Monogram in 2007 as Senior Director of Research and Development, Oncology. Prior to joining Monogram, he worked for twelve years at Berlex Biosciences where he was the Department Head of their Cancer Research Department. Previously, he held a variety of research positions in academia, including ten years at the University of California’s Lawrence Berkeley Laboratory. He is currently an Advisory Council Member for the California Breast Cancer Research Program. Dr. Parry received his PhD in Biochemistry at the University of London.
|
 |
|
Christos J. Petropoulos, PhD is Vice President of Research and Development, Virology and Chief Scientific Officer. He joined Monogram as Director of Research and Development in August 1996, became Senior Director of Research and Development in September 1997, was named Vice President, Research and Development in November 1999 and was named Vice President, Research and Development, Virology and Chief Scientific Officer in December 2004. From 1992 to 1996, Dr. Petropoulos was a scientist at Genentech where he headed the Molecular Virology Laboratory and the Research Virology and Molecular Detection Laboratories from 1994 to 1996. Dr. Petropoulos received his PhD in molecular and cell biology from Brown University.
|
 |
|
Michael G. Vicari is our Vice President of Sales. He joined Monogram in February, 2006 as Senior Director of Sales, and was named Vice President of Sales in March 2007. He currently oversees our Sales, Strategic Accounts, and Payer Relations functions. Mike brings 25 years of industry experience in sales, training, payer relations, and sales management. He has held senior sales management positions at biotechnology companies Genentech, Nuerex, Medimmune, and Corixa. He holds a BS in Organizational Behavior from University of San Francisco.
|
 |
|
William J. Welch has served as our Senior Vice President and Chief Commercial Officer since September 2005. From 1998 to 1999 and from 2001 to August 2005, Mr. Welch was with LaJolla Pharmaceutical, Inc., most recently as Vice President, Sales & Marketing. From 1999 to 2001, Mr. Welch was Vice President of Global Marketing for Dade Behring MicroScan where he managed marketing and strategic development for a $150 million business. From 1993 to 1998, Mr. Welch held a number of management positions with Abbott Laboratories, including General Manager of the Ambulatory Infusion Systems Division. Mr. Welch holds a BS from the University of California at Berkeley and an MBA from Harvard University.
|
 |
|
Jeannette M. Whitcomb, PhD is Vice President of Operations. She joined Monogram as one of the first scientists in the Research and Development department in 1996, transitioned to the Operations group in 2002 and was named Vice President of Operations in June 2003. Prior to joining Monogram, Dr. Whitcomb was a Postdoctoral Fellow in Dr. Stephen H. Hughes' lab at the National Cancer Institute — Frederick Cancer Research and Development Center. Prior to that, she was a Fogerty Fellow in Dr. Peter A. Cerutti's lab at the Swiss Institute for Experimental Cancer Research in Lausanne, Switzerland. Dr. Whitcomb received her bachelor's degree in biology from Widener University in Chester, Pennsylvania and her PhD in microbiology and immunology from Temple University School of Medicine in Philadelphia.
|
 |
|
Patricia Wray is the Vice President, Human Resources. She has overseen Monogram's Human Resources function in a number of capacities since 1998. Prior to joining Monogram, Ms. Wray held a number of postions at Genentech including Director of Employee Relations and Training. Before her employment with Genentech, Ms. Wray worked as Employee Relations Manager at Hewlett Packard in both the Networking and Analytical Instrument Divisions. She received her Masters degree from Michigan State University, and a BS in Horticulture from University of Delaware.
|
 |
|
|
|
 |
|
